Risk and protective factors for COVID-19 morbidity, severity, and mortality

J Zhang, X Dong, G Liu, Y Gao - Clinical reviews in allergy & immunology, 2023 - Springer
The outbreak of the coronavirus disease 2019 (COVID-19), caused by the novel severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become an evolving global …

[HTML][HTML] COVID-19 in early 2021: current status and looking forward

C Wang, Z Wang, G Wang, JYN Lau… - Signal Transduction and …, 2021 - nature.com
Since the first description of a coronavirus-related pneumonia outbreak in December 2019,
the virus SARS-CoV-2 that causes the infection/disease (COVID-19) has evolved into a …

COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives

M Nishiga, DW Wang, Y Han, DB Lewis… - Nature Reviews …, 2020 - nature.com
Abstract Coronavirus disease 2019 (COVID-19), caused by a strain of coronavirus known as
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global …

SARS-CoV-2 detection, viral load and infectivity over the course of an infection

KA Walsh, K Jordan, B Clyne, D Rohde, L Drummond… - Journal of Infection, 2020 - Elsevier
Objectives To summarise the evidence on the detection pattern and viral load of SARS-CoV-
2 over the course of an infection (including any asymptomatic or pre-symptomatic phase) …

COVID-19 in children: where do we stand?

GB Nikolopoulou, HC Maltezou - Archives of medical research, 2022 - Elsevier
From the beginning of the coronavirus disease 2019 (COVID-19) pandemic it became
evident that children infected with the severe acute respiratory syndrome coronavirus 2 …

COVID-19 in 7780 pediatric patients: a systematic review

A Hoang, K Chorath, A Moreira, M Evans… - …, 2020 - thelancet.com
Background Studies summarizing the clinical picture of COVID-19 in children are lacking.
This review characterizes clinical symptoms, laboratory, and imaging findings, as well as …

COVID-19 pathophysiology: A review

K Yuki, M Fujiogi, S Koutsogiannaki - Clinical immunology, 2020 - Elsevier
In December 2019, a novel coronavirus, now named as SARS-CoV-2, caused a series of
acute atypical respiratory diseases in Wuhan, Hubei Province, China. The disease caused …

Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis

R Mao, Y Qiu, JS He, JY Tan, XH Li, J Liang… - The lancet …, 2020 - thelancet.com
Background The prevalence and prognosis of digestive system involvement, including
gastrointestinal symptoms and liver injury, in patients with COVID-19 remains largely …

D-dimer level in COVID-19 infection: a systematic review

M Rostami, H Mansouritorghabeh - Expert review of hematology, 2020 - Taylor & Francis
Introduction COVID-19 disease has spread worldwide from December 2019 to the present
day; the early stage of this disease can be associated with high D-dimer, prolonged PT, and …

Drug repurposing approach to fight COVID-19

TU Singh, S Parida, MC Lingaraju, M Kesavan… - Pharmacological …, 2020 - Springer
Currently, there are no treatment options available for the deadly contagious disease,
coronavirus disease 2019 (COVID-19). Drug repurposing is a process of identifying new …